|Articles|September 12, 2022
Characterizing mRNA using SEC-MALS
Author(s)Wyatt
SEC-MALS quantifies biophysical attributes of mRNA, including molar mass, percent aggregates, Rg and Rh, and how they are affected by formulation and storage conditions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How Mitigation and Maintenance Protect Against Future Risk
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
